Cargando…
Pemetrexed for Recurrent Primary Central Nervous System Lymphoma in the Elderly: Results of a Retrospective Study
AIM: Primary central nervous system lymphoma (PCNSL) is an aggressive, destructive, and rapidly progressive malignant brain tumor. Although aggressive therapies were studied trying to increase the median survival of PCNSL, the high relapse rate of PCNSL is still a big problem for the oncology medici...
Autores principales: | Xiao, Jing, Wang, Shishu, Xu, Bing, Yu, Lisha, Han, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983235/ https://www.ncbi.nlm.nih.gov/pubmed/35392141 http://dx.doi.org/10.1155/2022/8963547 |
Ejemplares similares
-
Retracted: Pemetrexed for Recurrent Primary Central Nervous System Lymphoma in the Elderly: Results of a Retrospective Study
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study
por: Sun, Yi, et al.
Publicado: (2017) -
Primary Central Nervous System Lymphoma With Systemic Recurrence
por: Pandravada, Sasirekha, et al.
Publicado: (2021) -
Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II Study
por: Ma, Jingjing, et al.
Publicado: (2022) -
Primary central nervous system lymphoma
por: Löw, Sarah, et al.
Publicado: (2018)